Publications

Clewell HJ, Gentry PR, Gearhart JM, Covington TR, Banton MI, Andersen ME. 2001. Development of a physiologically based pharmacokinetic model of isopropanol and its metabolite acetone. Toxicol Sci 63(2):160–172; doi: 10.1093/toxsci/63.2.160.

Ebi K, Exuzides KA, Lau E, Kelsh MA, Barnstorm A. 2001. Association of normal weather periods and El Nino events with viral pneumonia hospitalization in females, California 1983–1998. Amer Pub Health Assoc J 91(8):1200–1208; doi: 10.2105/ajph.91.8.1200. PMID: 11499104.

Lau C, Mole ML, Copeland FM, Rogers JM, Kavlock RJ, Shuey DL, Cameron AM, Ellis DH, Logsdon TR, Merriman J, Setzer RW. 2001. Toward a biologically-based dose-response model for the developmental toxicity of 5-fluorouracil in the rat: Acquisition of experimental data. Toxicol Sci 59(1):37–48; doi: 10.1093/toxsci/59.1.37.

Setzer RW, Lau C, Mole ML, Copeland FM, Rogers JM, Kavlock RJ. 2001. Toward a biologically-based dose-response model for the developmental toxicity of 5-fluorouracil in the rat: A mathematical construct. Toxicol Sci 59(1):49–58; doi: 10.1093/toxsci/59.1.49.

Rogers JM, Hunter ES III. 2001. Toxicological highlight-Redox redux: A closer look at conceptual low molecular weight thiols. Toxicol Sci 62(1):1–3; doi: 10.1093/toxsci/62.1.1.

Huang Y-S, Held G, Andrews JE, Rogers JM. 2001. 14C-methanol incorporation into DNA and specific proteins of organogenesis-stage mouse embryos in vitro. Reprod Toxicol 15:429–435; doi: 10.1016/s0890-6238(01)00144-7.

Leazer TM, Rogers JM. 2001. Role of the acute phase response and tissue necrosis factor alpha in the developmental toxicity of lipopolysaccharide in the CD-1 mouse. Reprod Toxicol 16(2):173–179; doi: 10.1016/S0890-6238(02)00011-4.

Kolanz ME, Madl AK, Kelsh MA, Kent MS, Kalmes RM, Paustenbach DJ. 2001. A comparison and critique of historical and current exposure assessment methods for beryllium: Implications for evaluating risk of chronic beryllium disease. Appl Occup Environ Hyg 16(5):593–614; doi: 10.1080/10473220119613. PMID: 11370938.

Deubner D, Kelsh MA, Shum M, Maier L, Kent MS, Lau E. 2001. Beryllium sensitization, chronic beryllium disease, and exposures at a beryllium mining and extraction facility. Appl Occup Environ Hyg 16(5):579–592; doi: 10.1080/104732201750169697. PMID: 11370937.

Mandel J, Kelsh MA. 2001. A review of the epidemiology of trichloroethylene and kidney cancer. Hum Ecol Risk Assess 7(4):727–735; doi: 10.1080/20018091094600.

Lea IA, Sivashanmugam P, O’Rand MG. 2001. Zonadhesin: Characterization, localization, and zona pellucida binding. Biol Reprod 65(6):1691–700; doi: 10.1095/biolreprod65.6.1691.

Goodman M, Kelsh MA, Ebi KL, Ianuzzi J, Langholz B. 2001. Evaluation of potential confounders in planning a study of occupational magnetic field exposure and female breast cancer. Epidemiol 13:50–58.

Yager JW, Kelsh MA, Zhao K, Mrad RJ. 2001. Development of an occupational illness and injury surveillance database for the electric energy sector. Appl Occup Environ Hyg 16(2):291–294; doi: 10.1080/10473220121231. PMID: 11217725.

Albrecht B, Collins ND, Burniston MT, Nisbet JW, Ratner L, Green PL, Lairmore MD. 2000. Human T-lymphotropic virus type 1 open reading frame I p12I is required for efficient viral infectivity in primary lymphocytes. J Virol 74(21):9828–9835; doi: 10.1128/jvi.74.21.9828-9835.2000. PMID: 11024109.

Shipp AM, Gentry PR, Lawrence G, Van Landingham C, Covington T, Clewell HJ, Gribben K, Crump K. 2000. Determination of a site-specific reference dose for methylmercury for fish-eating populations. Toxicol Ind Health 16(9-10):335–438.

Smith DM, Grasty RC, Theodosiou NA, Tabin CJ, Nascone-Yoder NM.  2000. Evolutionary relationships between the amphibian, avian, and mammalian stomachs. Evolut Develop 2(6):348-59; doi: 10.1046/j.1525-142x.2000.00076.x.

Mcnamara JF, Lombardo H, Pillai SK, Jensen I, Albericio F, Kates SK. 2000. An efficient solid-phase strategy for the construction of chemokines. J Pept Sci 6(10):512–518; doi: 10.1002/1099-1387(200010)6:10<512::AID-PSC269>3.0.CO;2-A.

Newbound GC, O’Rourke JP, Collins ND, Andrews JM, DeWille J, Lairmore MD. 2000. Repression of tax-mediated human T-lymphotropic virus type 1 transcription by inducible cAMP early repressor (ICER) protein in peripheral blood mononuclear cells. J Med Virol 62(2):286–292; doi: 10.1002/1096-9071(200010)62:2<286::AID-JMV22>3.0.CO;2-Y.  PMID: 11002260.

Andersen ME, Sarangapani R, Gentry PR, Clewell HJ, Covington TR, Frederick CB. 2000. Application of a hybrid CFD-PBPK nasal dosimetry model in an inhalation risk assessment: An example with acrylic acid. Toxicol Sci 57:312–325.

Thompson CM, Capdevila JH, Strobel HW. 2000. Recombinant P450 2D18 metabolism of dopamine and arachidonic acid. J Pharmacol Exper Ther 294(3):1120–1130; doi: 10.1016/S0022-3565(24)39180-3.